Centric Health Corp. (TSE:CRX – Free Report) – Analysts at Desjardins decreased their FY2024 EPS estimates for shares of Centric Health in a report issued on Monday, July 29th. Desjardins analyst G. Ho now anticipates that the company will post earnings of $0.00 per share for the year, down from their previous forecast of $0.01. Desjardins also issued estimates for Centric Health’s FY2025 earnings at $0.10 EPS.
Centric Health (TSE:CRX – Get Free Report) last announced its earnings results on Friday, May 10th. The company reported C($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.02) by C$0.01. The company had revenue of C$89.73 million during the quarter, compared to analyst estimates of C$89.80 million.
Centric Health Price Performance
Featured Stories
- Five stocks we like better than Centric Health
- Overbought Stocks Explained: Should You Trade Them?
- Should You Invest in Bitcoin? Pros and Cons
- Financial Services Stocks Investing
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
